APA (7th ed.) Citation

Santhireswaran, A., LaRue, S., Chaudhry, S., Liu, Y., Suda, K., Mohamed, O., . . . Tadrous, M. (2025). Impact of pregabalin reclassification as a controlled substance in Egypt on gabapentinoid and opioid utilization: A repeated cross-sectional study. PLoS ONE, 20(12), 1. https://doi.org/10.1371/journal.pone.0337833

Chicago Style (17th ed.) Citation

Santhireswaran, Araniy, Simon LaRue, Shanzeh Chaudhry, Yilei Liu, Katie Suda, Omneya Mohamed, Mohamed Amin, Jason Guertin, and Mina Tadrous. "Impact of Pregabalin Reclassification as a Controlled Substance in Egypt on Gabapentinoid and Opioid Utilization: A Repeated Cross-sectional Study." PLoS ONE 20, no. 12 (2025): 1. https://doi.org/10.1371/journal.pone.0337833.

MLA (9th ed.) Citation

Santhireswaran, Araniy, et al. "Impact of Pregabalin Reclassification as a Controlled Substance in Egypt on Gabapentinoid and Opioid Utilization: A Repeated Cross-sectional Study." PLoS ONE, vol. 20, no. 12, 2025, p. 1, https://doi.org/10.1371/journal.pone.0337833.